Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2009 1
2010 1
2013 1
2014 1
2015 2
2016 1
2018 1
2019 1
2020 3
2021 2
2022 2
2023 1
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Gene Therapy in Head and Neck Cancer.
Farmer ZL, Kim ES, Carrizosa DR. Farmer ZL, et al. Among authors: carrizosa dr. Oral Maxillofac Surg Clin North Am. 2019 Feb;31(1):117-124. doi: 10.1016/j.coms.2018.08.006. Epub 2018 Oct 25. Oral Maxillofac Surg Clin North Am. 2019. PMID: 30454787 Review.
Planned Dental Extractions After Radiation Therapy.
Ward MC, Petersen CM, Noll J, Bernard MS, Kuremsky JG, Patel A, Baldwin C, Morgan J, Thakkar VV, Atlas JL, Carrizosa DR, Prabhu R, Moeller BJ, Milas ZL, Brickman DS, Frenkel CH, Brennan MT. Ward MC, et al. Among authors: carrizosa dr. JAMA Otolaryngol Head Neck Surg. 2024 Oct 1;150(10):851-858. doi: 10.1001/jamaoto.2024.2353. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 39115868
New targets and new mechanisms in lung cancer.
Carrizosa DR, Mileham KF, Haggstrom DE. Carrizosa DR, et al. Oncology (Williston Park). 2013 May;27(5):396-404. Oncology (Williston Park). 2013. PMID: 25184262 Free article. Review.
Defining targets to improve care delivery for T4 larynx squamous cell carcinoma.
Frenkel CH, Brickman DS, Trufan SJ, Ward MC, Moeller BJ, Carrizosa DR, Sumrall AL, Milas ZL. Frenkel CH, et al. Among authors: carrizosa dr. Laryngoscope Investig Otolaryngol. 2022 Nov 16;7(6):1849-1856. doi: 10.1002/lio2.959. eCollection 2022 Dec. Laryngoscope Investig Otolaryngol. 2022. PMID: 36544914 Free PMC article.
Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design.
Fleming CW, Ward MC, Woody NM, Joshi NP, Greskovich JF Jr, Rybicki L, Xiong D, Contrera K, Chute DJ, Milas ZL, Frenkel CH, Brickman DS, Carrizosa DR, Ku J, Prendes B, Lamarre E, Lorenz RR, Scharpf J, Burkey BB, Schwartzman L, Geiger JL, Adelstein DJ, Koyfman SA. Fleming CW, et al. Among authors: carrizosa dr. Oral Oncol. 2021 Jan;112:105046. doi: 10.1016/j.oraloncology.2020.105046. Epub 2020 Oct 28. Oral Oncol. 2021. PMID: 33129058
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients.
Farhangfar CJ, Scarola GT, Morris VA, Farhangfar F, Dumas K, Symanowski J, Hwang JJ, Mileham KF, Carrizosa DR, Naumann RW, Livasy C, Kim ES, Raghavan D. Farhangfar CJ, et al. Among authors: carrizosa dr. JCO Clin Cancer Inform. 2022 Jul;6:e2200011. doi: 10.1200/CCI.22.00011. JCO Clin Cancer Inform. 2022. PMID: 35839431 Free article.
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Worden FP, Pisick E, Rothe M, Mangat PK, Garrett-Mayer E, Khalil MF, Carrizosa DR, Bauman JR, Leidner RS, Duvivier HL, Fu S, Park MS, Yost KJ, Calfa CJ, Marr AS, Balmanoukian AS, Behl D, Cannon TL, Nabell L, Powell SF, Thota R, Hinshaw DC, Gregory A, Grantham GN, Halabi S, Schilsky RL. Worden FP, et al. Among authors: carrizosa dr. JCO Precis Oncol. 2024 Oct;8:e2400477. doi: 10.1200/PO-24-00477. Epub 2024 Oct 16. JCO Precis Oncol. 2024. PMID: 39413339 Clinical Trial.
Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929.
Karim NA, Miao J, Reckamp KL, Gay CM, Byers LA, Zhao YQ, Redman MW, Carrizosa DR, Wang WL, Petty WJ, Mehta K, Faller BA, Agamah ES, Kasbari SS, Malisetti RK, Kumar A, Schallenkamp J, Alluri KC, Gray JE, Kelly K. Karim NA, et al. Among authors: carrizosa dr. J Thorac Oncol. 2024 Nov 4:S1556-0864(24)02431-6. doi: 10.1016/j.jtho.2024.10.021. Online ahead of print. J Thorac Oncol. 2024. PMID: 39505259
21 results